Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A L Morgan

Showing results (71-80 of 79) with videos related to

Pageof 8
Sort By:
You have reached the last page of results.This site can display upto 79 results.
European Journal of Cancer (Oxford, England : 1990)|December 31, 2002
Shortened irradiation scheme, continuous infusion of 5-fluorouracil and fractionation of mitomycin C in locally advanced anal carcinomas. Results of a phase II study of the European Organization for Research and Treatment of Cancer. Radiotherapy and Gastrointestinal Cooperative GroupsJ F Bosset, F Roelofsen, D A L Morgan, et al.
British Journal of Cancer|March 31, 2011
Long-term clinical outcome of oestrogen receptor-positive operable primary breast cancer in older women: a large series from a single centreB M Syed, W Al-Khyatt, S J Johnston, et al.
European Journal of Cancer (Oxford, England : 1990)|March 26, 2013
Radiotherapy or tamoxifen after conserving surgery for breast cancers of excellent prognosis: British Association of Surgical Oncology (BASO) II trialR W Blamey, T Bates, U Chetty, et al.
European Journal of Cancer (Oxford, England : 1990)|February 27, 2007
Survival of invasive breast cancer according to the Nottingham Prognostic Index in cases diagnosed in 1990-1999R W Blamey, I O Ellis, S E Pinder, et al.
European Journal of Cancer (Oxford, England : 1990)|September 2, 2008
Predictors of the risk of fibrosis at 10 years after breast conserving therapy for early breast cancer: a study based on the EORTC Trial 22881-10882 'boost versus no boost'Sandra Collette, Laurence Collette, Tom Budiharto, et al.
Mammalian Genome : Official Journal of the International Mammalian Genome Society|January 1, 1997
Cosmid-derived markers anchoring the bovine genetic map to the physical mapL Ferretti, B G Urquhart, A Eggen, et al.
JAMA Oncology|September 9, 2016
Prognostic Factors for Local Control in Breast Cancer After Long-term Follow-up in the EORTC Boost vs No Boost Trial: A Randomized Clinical TrialConny Vrieling, Erik van Werkhoven, Philippe Maingon, et al.
The Lancet. Oncology|March 22, 2008
The UK Standardisation of Breast Radiotherapy (START) Trial A of radiotherapy hypofractionation for treatment of early breast cancer: a randomised trial, S M Bentzen, R K Agrawal, et al.
Lancet (London, England)|March 22, 2008
The UK Standardisation of Breast Radiotherapy (START) Trial B of radiotherapy hypofractionation for treatment of early breast cancer: a randomised trial, S M Bentzen, R K Agrawal, et al.
Pageof 8

Showing results (71-80 of 79) with videos related to

Sort By:
Pageof 8
You have reached the last page of results.This site can display upto 79 results.
European Journal of Cancer (Oxford, England : 1990)|December 31, 2002
Shortened irradiation scheme, continuous infusion of 5-fluorouracil and fractionation of mitomycin C in locally advanced anal carcinomas. Results of a phase II study of the European Organization for Research and Treatment of Cancer. Radiotherapy and Gastrointestinal Cooperative GroupsJ F Bosset, F Roelofsen, D A L Morgan, et al.
British Journal of Cancer|March 31, 2011
Long-term clinical outcome of oestrogen receptor-positive operable primary breast cancer in older women: a large series from a single centreB M Syed, W Al-Khyatt, S J Johnston, et al.
European Journal of Cancer (Oxford, England : 1990)|March 26, 2013
Radiotherapy or tamoxifen after conserving surgery for breast cancers of excellent prognosis: British Association of Surgical Oncology (BASO) II trialR W Blamey, T Bates, U Chetty, et al.
European Journal of Cancer (Oxford, England : 1990)|February 27, 2007
Survival of invasive breast cancer according to the Nottingham Prognostic Index in cases diagnosed in 1990-1999R W Blamey, I O Ellis, S E Pinder, et al.
European Journal of Cancer (Oxford, England : 1990)|September 2, 2008
Predictors of the risk of fibrosis at 10 years after breast conserving therapy for early breast cancer: a study based on the EORTC Trial 22881-10882 'boost versus no boost'Sandra Collette, Laurence Collette, Tom Budiharto, et al.
Mammalian Genome : Official Journal of the International Mammalian Genome Society|January 1, 1997
Cosmid-derived markers anchoring the bovine genetic map to the physical mapL Ferretti, B G Urquhart, A Eggen, et al.
JAMA Oncology|September 9, 2016
Prognostic Factors for Local Control in Breast Cancer After Long-term Follow-up in the EORTC Boost vs No Boost Trial: A Randomized Clinical TrialConny Vrieling, Erik van Werkhoven, Philippe Maingon, et al.
The Lancet. Oncology|March 22, 2008
The UK Standardisation of Breast Radiotherapy (START) Trial A of radiotherapy hypofractionation for treatment of early breast cancer: a randomised trial, S M Bentzen, R K Agrawal, et al.
Lancet (London, England)|March 22, 2008
The UK Standardisation of Breast Radiotherapy (START) Trial B of radiotherapy hypofractionation for treatment of early breast cancer: a randomised trial, S M Bentzen, R K Agrawal, et al.
Pageof 8